adjustment disorder Archives - Psylabs

Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development

Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine [...]

By John Thorne|2026-08-24T17:30:20+02:00August 24, 2026|Press Releases|0 Comments

Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder

Dosing initiates clinical evaluation of NPX-5, a GMP-compliant, nature-derived psilocybin [...]

By John Thorne|2026-07-28T16:39:16+02:00July 28, 2026|Uncategorized|0 Comments

Naturally Derived Psychoactive Products for Research and Clinical Programs.

Naturally Derived Psychoactive Products for Research and Clinical Programs.

About Us

Our Science

Products

Contact Us

info@psylabs.life
Investor inquiries: tony@psylabs.life

© 2026 Psylabs. All Rights Reserved. All content on this website is protected by copyright law. You may not reproduce or distribute any part of this content without the written permission of Psylabs.

Website and brand design by Fort Hartley Brand Consultants

© 2026 Psylabs. All Rights Reserved. All content on this website is protected by copyright law. You may not reproduce or distribute any part of this content without the written permission of Psylabs.